NinePointTwo Capital’s Kodiak Sciences KOD Stock Holding History

NinePointTwo Capital’s Portfolio KOD Stock Details KOD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-56,642	Closed	-$432K	–	209
2022 Q2	$432K	Sell	56,642 -5,228	-8%	-$36.7K	0.15%	46
2022 Q1	$477K	Buy	+61,870	New	+$2.41M	0.13%	47

Other funds holding KOD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NinePointTwo Capital's KOD Position: Q3 2022 in Review

NinePointTwo Capital sold out of Kodiak Sciences (KOD) in Q3 2022, closing a stake of 56,642 shares — an estimated $432K sold.

NinePointTwo Capital first reported a position in KOD in Q1 2022 and held it in 2 quarters. The position peaked at $477K in Q1 2022. 143 funds tracked by Wall St. Rank hold KOD as of Q3 2022.

NinePointTwo Capital reported no remaining Kodiak Sciences position as of Q3 2022 after selling out during the quarter.
NinePointTwo Capital sold 56,642 Kodiak Sciences shares in Q3 2022, an estimated $432K.
NinePointTwo Capital first reported a position in Kodiak Sciences in Q1 2022 and held it in 2 quarters.
NinePointTwo Capital's Kodiak Sciences position peaked at $477K in Q1 2022.
143 funds tracked by Wall St. Rank held Kodiak Sciences as of Q3 2022.

Based on NinePointTwo Capital's 13F filing for Q3 2022, filed 14 Nov 2022.